Exhibit 99.1 Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update Received U.S. Food and Drug Administration (FDA) approval for IBTROZI™ (taletrectinib), a next-generation oral treatment for advanced ROS1- positive (ROS1+) non-small cell lung cancer (NSCLC) on June 11, 2025 Successfully started 70 patients on IBTROZI as of July 31, 2025, approximately seven weeks after U.S. FDA approval National Comprehensive Cancer Network® added taletrectinib (IBTROZI) as a Preferred Opt ...

Exhibit 99.1 WhiteHorse Finance, Inc. Announces Second Quarter 2025 Earnings Results and Declares Quarterly Distribution of $0.385 Per Share NEW YORK, August 7, 2025 /PRNewswire/ -- WhiteHorse Finance, Inc. ("WhiteHorse Finance" or the "Company") (Nasdaq: WHF) today announced its financial results for the second quarter ended June 30, 2025. In addition, the Company's board of directors has declared a distribution of $0.385 per share with respect to the quarter ended June 30, 2025. The distribution will be p ...

Wholly Owned Portfolio PBGENE-HBV (Viral Elimination Program): PBGENE-HBV is Precision's wholly owned in vivo gene editing program under investigation in a global first-in-human clinical trial, which is designed to be a potentially curative treatment for chronic Hepatitis B infection. PBGENE-HBV is the first and only potentially curative gene editing program to enter the clinic that is specifically designed to eliminate the root cause of chronic Hepatitis B, cccDNA, while inactivating integrated HBV DNA. Th ...

Exhibit 99.1 "Looking ahead to the balance of the year, assuming a normalized retail margin environment, and further improvement and growth at GREW led by Diversegy and Genie Solar, we continue to expect that Genie will generate $40 to $50 million of consolidated Adjusted EBITDA in 2025." Second Quarter 2025 Highlights (Unless otherwise noted, 2Q25 results are compared to 2Q24, and results of the former Genie Retail Energy International (GREI) segment are included in discontinued operations for all periods. ...

Exhibit 99.1 UNITED HOMES GROUP, INC. REPORTS 2025 SECOND QUARTER RESULTS Second Quarter 2025 Highlights COLUMBIA, SC., August 7, 2025 / United Homes Group, Inc. (the "Company") (NASDAQ: UHG) today announced results for the three and six months ended June 30, 2025. Second Quarter 2025 Operating Results For the second quarter 2025, net loss was $6.3 million, or $0.11 per diluted share, which included a loss from the change in fair value of derivative liabilities of $6.2 million, with that change predominantl ...

Second Quarter 2025 Operating Results For the second quarter 2025, net loss was $6.3 million, or $0.11 per diluted share, which included a loss from the change in fair value of derivative liabilities of $6.2 million, with that change predominantly due to changes in fair value on potential earn-out consideration due to fluctuation in the stock price during the measurement period, representing a non-cash item. The earnout consideration would be paid in common shares upon reaching certain stock price hurdles. ...

Exhibit 99.1 FOR IMMEDIATE RELEASE Cogent Contacts: For Public Relations: For Investor Relations: Jocelyn Johnson John Chang + 1 (202) 295-4299 + 1 (202) 295-4212 jajohnson@cogentco.com investor.relations@cogentco.com Cogent Communications Reports Second Quarter Results, Increases its Regular Quarterly Dividend on its Common Stock and Increases its Stock Buyback Program by $100.0 Million Financial and Business Highlights Page 1 of 24 · Service revenue was $246.2 million for Q2 2025 and was $247.0 million fo ...

Second Quarter 2025 Results Earnings Presentation 10 Important Disclosures IMPORTANT NOTICES The inclusion of references to P10, Inc. ("P10" or the "Company") in this presentation is for information purposes only as the holding company of various subsidiaries. P10 does not offer investment advisory services and this presentation is neither an offer of any investment products nor an offer of advisory services by P10. By accepting this presentation, you acknowledge that P10 is not offering investment advisory ...

Vital Farms Reports Second Quarter 2025 Financial Results Second Quarter Net Revenue of $184.8 Million, Up 25.4% Versus Prior Year Period Raises Fiscal Year 2025 Net Revenue Outlook to At Least $770 Million, 27% Increase from 2024 Results, Reflecting Strong Consumer Demand and Successful Strategic Pricing Actions; Increases Adjusted EBITDA Guidance to At Least $110 Million On Track to Reach $1 Billion Net Revenue Target in 2027 AUSTIN, TX – August 7, 2025 – Vital Farms (Nasdaq: VITL), a Certified B Corporat ...

Exhibit 99.1 Chicago Atlantic Real Estate Finance Announces Second Quarter 2025 Financial Results Extends Revolving Credit Facility Maturity to 2028 Subsequent Portfolio Activity ● During the subsequent period from July 1, 2025, to August 7, 2025, the Company received unscheduled principal repayments totaling approximately $56.8 million, relating to the full prepayment of six credit facilities. In connection with these prepayments, the Company received and recognized approximately $1.0 million in prepayment ...